STOCK TITAN

Ventas Stock Price, News & Analysis

VTR NYSE

Welcome to our dedicated page for Ventas news (Ticker: VTR), a resource for investors and traders seeking the latest updates and insights on Ventas stock.

Ventas, Inc. (VTR) is a leading healthcare real estate investment trust (REIT) specializing in senior housing communities, medical offices, and life science facilities. This page serves as the definitive source for official company announcements and market-moving developments.

Investors and industry professionals will find timely updates including quarterly earnings reports, property portfolio expansions, and strategic partnerships. Our curated news collection provides essential insights into operational milestones across Ventas' diversified healthcare assets.

Key coverage areas include senior housing market trends, medical office lease agreements, and research facility developments. All content is verified through primary sources to ensure accuracy and compliance with financial disclosure standards.

Bookmark this page for streamlined access to Ventas' latest press releases and sector analysis. Regularly updated to reflect new developments impacting this healthcare REIT's market position.

Rhea-AI Summary

Ventas, Inc. announced the pricing of $500 million aggregate principal amount of 5.625% Senior Notes due 2034. The Notes will be fully and unconditionally guaranteed by the Company and mature on July 1, 2034. The proceeds will be used for general corporate purposes, including repayment of other indebtedness.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.23%
Tags
none
-
Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) will participate in investor meetings at the BMO 2024 Real Estate Conference on May 8, 2024. Ventas is a leading S&P 500 real estate investment trust focused on providing exceptional environments for the aging population through senior housing communities and healthcare facilities across North America and the United Kingdom.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.17%
Tags
conferences
-
Rhea-AI Summary

Ventas, Inc. (NYSE: VTR) reported positive first quarter 2024 results with a Net Loss per share of ($0.04), Normalized FFO per share of $0.78 (+5% YoY) and Total Company NOI growth of 8.2%. The company experienced strong demand in senior housing, leading to accelerated occupancy growth and improved guidance for the full year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.5%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.57%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.23%
Tags
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.56%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.7%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.53%
Tags
dividends earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.23%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.23%
Tags
none

FAQ

What is the current stock price of Ventas (VTR)?

The current stock price of Ventas (VTR) is $64.77 as of July 11, 2025.

What is the market cap of Ventas (VTR)?

The market cap of Ventas (VTR) is approximately 28.4B.
Ventas

NYSE:VTR

VTR Rankings

VTR Stock Data

28.41B
448.76M
0.57%
99.91%
2.85%
REIT - Healthcare Facilities
Real Estate Investment Trusts
Link
United States
CHICAGO